The latest investment in Achieve's unique workforce fund, Celito Tech addresses growing demand for industry-specific quality assurance and IT services in life sciences

Achieve独家劳动力基金的最新投资，Celito Tech满足了生命科学领域对行业特定质量保证和IT服务不断增长的需求。

NEW YORK

纽约

,

，

May 27, 2026

2026年5月27日

/PRNewswire/ -- Achieve Partners today announced an investment in Celito Tech ('Celito'), a Palo Alto-based firm that provides tailored regulatory, compliance, and IT services designed to meet the needs of biotech and life sciences companies. The investment is the latest in Achieve's

/PRNewswire/ -- Achieve Partners 今日宣布投资位于帕洛阿尔托的公司 Celito Tech（“Celito”），该公司为生物技术和生命科学公司提供量身定制的监管、合规和 IT 服务。这项投资是 Achieve 的最新举措。

recently announced

最近宣布

Workforce II Fund, which invests in high-growth companies in sectors facing critical talent shortages and builds apprenticeship programs to both close those workforce gaps and accelerate growth.

劳动力发展基金II，该基金投资于面临关键人才短缺的高增长行业，并建立学徒计划以缩小这些劳动力缺口并加速增长。

Continue Reading

继续阅读

Celito

塞利托

'Biotech companies have always operated in one of the most demanding regulatory environments imaginable, and as AI reshapes the industry and catalyzes drug development, the compliance demands and technical challenges they face will only become more complex,' said Vikas Kawatra, CEO and Co-Founder of Celito.

“生物技术公司一直在想象中最苛刻的监管环境中运营，随着人工智能重塑行业并推动药物开发，它们面临的合规要求和技术挑战只会变得更加复杂，”Celito首席执行官兼联合创始人维卡斯·卡瓦特拉表示。

'Joining the Achieve portfolio gives us the resources and talent infrastructure to dramatically expand our reach, while staying true to the mission that has driven our growth from day one: helping biotech companies navigate that complexity so they can focus on developing new life-saving therapies.'.

“加入Achieve产品组合为我们提供了资源和人才基础设施，可以大幅扩展我们的覆盖范围，同时始终忠于自始至终推动我们发展的使命：帮助生物技术公司应对复杂性，从而专注于开发新的救命疗法。”

The biotech industry operates under a complex and ever-evolving web of regulations that govern everything from preclinical research and clinical trials to drug manufacturing and commercialization. Compliance failures can trigger costly remediation projects, delay product launches, or invite enforcement action, raising the stakes for companies that lack robust regulatory and IT infrastructure.

生物技术行业在复杂且不断演变的法规网络下运作，这些法规涵盖了从临床前研究、临床试验到药品生产和商业化的方方面面。合规失败可能引发代价高昂的补救项目、延误产品上市，或招致执法行动，这对缺乏强大监管和IT基础设施的公司而言，风险尤为突出。

At the same time, as AI begins to transform drug discovery and clinical operations, biotech companies face mounting pressure to integrate new technologies into their existing systems in ways that streamline the development process without disrupting ongoing programs..

同时，随着人工智能开始改变药物发现和临床操作，生物技术公司面临越来越大的压力，需要以不破坏正在进行的项目的方式，将新技术整合到现有系统中以简化开发流程。

Against this backdrop, demand is surging for specialized partners like Celito, which provides fractional, multi-disciplinary teams capable of designing and executing the full technology and compliance roadmap across a company's lifecycle. The firm's offerings include clinical quality assurance, regulatory and audit readiness, medical affairs enablement, enterprise application management, and a broad suite of IT services, including cybersecurity and cloud migration..

在此背景下，像 Celito 这样提供专业化服务的合作伙伴需求激增。Celito 提供由多学科团队组成的部分时间服务，能够设计并执行覆盖企业全生命周期的技术与合规路线图。该公司的服务包括临床质量保证、法规与审计准备、医学事务支持、企业应用管理，以及涵盖网络安全和云迁移在内的一整套广泛的IT服务。

As part of the Achieve portfolio, Celito will formalize its talent development programs, building on its existing success with internship and co-op initiatives, to create scalable apprenticeship pathways into life sciences tech and compliance careers.

作为Achieve项目组合的一部分，Celito将正式推出其人才发展计划，在其实习和合作项目现有成功的基础上，创建可扩展的学徒路径，以进入生命科学技术和合规职业领域。

'The biotech industry is at an inflection point as the opportunities presented by AI and emerging technology meet the regulatory and compliance regime that governs the field. More than ever, promising life sciences companies need support to help navigate this landscape,' said Lauren Goldman, Vice President at Achieve Partners.

“生物技术行业正处于一个转折点，人工智能和新兴技术带来的机遇与该领域遵循的监管和合规制度相遇。比以往任何时候都更需要支持，来帮助有前途的生命科学公司驾驭这一局面，”Achieve Partners副总裁劳伦·戈德曼表示。

'What sets the Celito team apart is their combination of deep market knowledge and IT expertise, which makes them uniquely qualified to close the talent gaps at the intersection of these disciplines. We're excited to bring Achieve's workforce strategy to bear on accelerating Celito's growth.'.

“Celito团队的与众不同之处在于他们将深厚的市场知识和IT专业知识相结合，这使他们在这些学科的交汇处填补人才缺口方面具备独特资格。我们很高兴能够运用Achieve的劳动力战略来加速Celito的增长。”

About Achieve Partners

关于Achieve Partners

Achieve Partners is engineering the future of learning and earning by investing in cutting edge technologies and novel business models to bolster skill development and secure the future of work for millions of Americans. By harnessing digital transformation to build new models for learning and new pathways to good jobs, Achieve is helping to level the playing field, improve socioeconomic mobility, and rekindle the American Dream..

Achieve Partners正在通过投资前沿技术和新颖的商业模式，推动学习与赚钱的未来，以促进技能发展并为数百万美国人保障工作的未来。通过利用数字化转型构建新的学习模式和通往优质工作的新途径，Achieve正在帮助拉平竞争环境、提升社会经济流动性，并重燃美国梦。

www.achievepartners.com

www.achievepartners.com

About Celito Tech

关于Celito科技

Celito Tech is a life sciences consulting firm providing technology-enabled regulatory, compliance, and IT services to biotech companies. The Company delivers a range of industry-specific solutions, including clinical quality assurance and medical affairs enablement, alongside IT services such as cybersecurity, cloud migration, and Veeva support.

Celito Tech是一家生命科学咨询公司，为生物技术公司提供技术支持的监管、合规和IT服务。公司提供一系列行业特定的解决方案，包括临床质量保证和医学事务支持，以及网络安全、云迁移和Veeva支持等IT服务。

.

。

Celito is led by its two cofounders Vikas Kawatra (CEO) and  Ravi Monangi (CTO), as well as Justin Lawrence; all bringing extensive experience across healthcare and life sciences.

Celito由其两位联合创始人维卡斯·卡瓦特拉（首席执行官）和拉维·莫南吉（首席技术官），以及贾斯汀·劳伦斯领导；他们在医疗保健和生命科学领域都带来了丰富的经验。

SOURCE Achieve Partners

来源：Achieve Partners

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示